MASSACHUSETTS INSTITUTE OF TECHNOLOGY;WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
发明人:
申请号:
IL24137415
公开号:
IL241374D0
申请日:
2015.09.09
申请国别(地区):
IL
年份:
2015
代理人:
摘要:
The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and pharmaceutical compositions thereof. The present invention also provides methods and kits using the inventive compounds and pharmaceutical compositions for treating and/or preventing diseases associated with protein aggregation, such as amyloidoses (e.g., Parkinson's disease and Alzheimer's disease), treating and/or preventing neurodegenerative diseases, treating and/or preventing diseases associated with Tar DNA binding protein 43 kDa, reducing or preventing protein aggregation, and/or modulating E3 ubiquitin ligase in a subject in need thereof.